The future of endoscopic treatment of early Barrett neoplasia: The endoscopist's view

Endoscopy

Volumn 40, Issue 12, 2008, Pages 1041-1047

  Falk, G W ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; PHOTOFRIN; PROTON PUMP INHIBITOR;

ARGON PLASMA COAGULATION; BARRETT ESOPHAGUS; CLINICAL TRIAL; CRYOTHERAPY; DYSPLASIA; EARLY CANCER; ELECTROCOAGULATION; ENDOSCOPIC ABLATION; ENDOSCOPIC SURGERY; ENDOSCOPIC THERAPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS MUCOSA; ESOPHAGUS PERFORATION; ESOPHAGUS RESECTION; ESOPHAGUS STRICTURE; FOLLOW UP; HUMAN; INTESTINE METAPLASIA; MEDICAL SPECIALIST; NONHUMAN; PATIENT SELECTION; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; SINGLE DRUG DOSE; SURGICAL TECHNIQUE;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CATHETER ABLATION; CRYOSURGERY; DISSECTION; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; ESOPHAGUS; FORECASTING; HUMANS; MUCOUS MEMBRANE; MULTICENTER STUDIES AS TOPIC; PRECANCEROUS CONDITIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 58149085438     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1103410     Document Type: Review

References (52)

1. Brandt LJ, Kauvar DR. Laser-induced transient regression of Barrett's epithelium. Gastrointest Endosc 1992: 38: 619-622
2. Berenson MM, Johnson TD, Markowitz NR et al. Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium. Gastroenterology 1993; 104: 1686-1691
3. Garewal H, Ramsey L, Sharma P et al. Biomarker studies in reversed Barrett's esophagus. Am J Gastroenterol 1999; 94: 2829-2833
4. Ackroyd R, Brown NJ, Davis MF et al. Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial. Gut 2000; 47: 612-617
5. Bergman JJ, Fockens P. Ablating Barrett's metaplastic epithelium: are the techniques ready for clinical use? Gut 2006; 55: 1222-1223
6. Schoenfeld P, Scheiman J. An evidence-based approach to studies of gastrointestinal therapies. Clin Gastroenterol Hepatol 2003; 1: 57-63
7. Spechler SJ. Thermal ablation of Barrett's esophagus: a heated debate. Am J Gastroenterol 2006; 101: 1770-1772
8. Van Laethem JL, Peny MO et al. Intramucosal adenocarcinoma arising under squamous re-epithelialisation of Barrett's oesophagus. Gut 2000; 46: 574-577
9. Shand A, Dallal H, Palmer K et al. Adenocarcinoma arising in columnar lined oesophagus following treatment with argon plasma coagulation. Gut 2001; 48: 580-581
10. Mino-Kenudson M, Ban S, Ohana M et al. Buried dysplasia and early adenocarcinoma arising in Barrett esophagus after porfimer-photodynamic therapy. Am J Surg Pathol 2007: 31: 403-409
11. Krishnadath KK, Wang KK, Taniguchi K et al. Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy. Gastroenterology 2000; 119: 624-630
12. Hage M, Siersema PD, Vissers KJ et al. Molecular evaluation of ablative therapy of Barrett's oesophagus. J Pathol 2005; 205: 57-64
13. Hage M, Siersema PD, Vissers KJ et al. Genomic analysis of Barrett's esophagus after ablative therapy: persistence of genetic alterations at tumor suppressor loci. Int J Cancer 2006; 118: 155-160
14. Dvorak K, Ramsey L, Payne CM et al. Abnormal expression of biomarkers in incompletely ablated Barrett's esophagus. Ann Surg 2006; 244: 1031-1036
15. Pech O, Nagy CD, Gossner L et al. Photodynamic therapy of human Barrett's cancer using 5-aminolaevulinic acid-induced protoporphyrin IX: an in-vivo dosimetry study in athymic nude mice. Eur J Gastroenterol Hepatol 2002; 14: 657-662
16. Johnston CM, Schoenfeld LP, Mysore JV et al. Endoscopic spray cryotherapy: a new technique for mucosal ablation in the esophagus. Gastro-intest Endosc 1999; 50: 86-92
17. Pasricha PJ, Hill S, Wadwa KS et al. Endoscopic cryotherapy: experimental results and first clinical use. Gastrointest Endosc 1999; 49: 627-631
18. Johnston MH. Cryotherapy and other newer techniques. Gastrointest Endosc Clin N Am 2003; 13: 491-504
19. Prasad GA, Wang KK, Buttar NS et al. Long term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology 2007; 132: 1226-1233
20. Das A, Singh V, Fleischer DE et al. A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. Am J Gastroenterol 2008; 103: 1340-1345
21. Kelty CJ, Ackroyd R, Brown NJ et al. Endoscopic ablation of Barrett's oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation. Aliment Pharmacol Ther 2004: 20: 1289-1296
22. Dulai GS, Jensen DM, Cortina G et al. Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus. Gastrointest Endosc 2005; 61: 232-240
23. Sharma P, Wani S, Weston AP et al. A randomised controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: longterm results. Gut 2006; 55: 1233-1239
24. Overholt BF, Lightdale CJ, Wang KK et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. Gastrointest Endosc 2005; 62: 488-498
25. Shaheen NJ, Sharma P, Overholt BF et al. A randomized, multicenter, sham-controlled trial of radiofrequency ablation for subjects with Barrett's esophagus containing dysplasia: interim results of the AIM dysplasia trial. Gastroenterology 2008; 134: A37
26. Overholt BF, Wang KK, Burdick JS et al. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. Gastrointest Endosc 2007; 66: 460-468
27. Ganz RA, Utley DS, Stem RA et al. Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus. Gastrointest Endosc 2004; 60: 1002-1010
28. Dunkin BJ, Martinez J, Bejarano PA et al. Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device. Surg Enclosc 2006; 20: 125-130
29. Sharma VK, Wang KK, Overholt BF et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc 2007; 65: 185-195
30. Fleischer DE, Overholt BF, Sharma VK et al. Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up. Gastrointest Endosc 2008; Jun 16 [Epub ahead of print]
31. Ell C, May A, Pech O et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointest Endosc 2007; 65: 3-10
32. Wang KK, Sampliner RE. Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 2008; 103: 788-797
33. Gondrie JJ, Pouw RE, Sondermeijer CM et al. Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy 2008; 40: 370-379
34. Gondrie JJ, Pouw RE, Sondermeijer CM et al. Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the first prospective series of 11 patients. Endoscopy 2008; 40: 359-369
35. Johnston MH, Eastone JA, Horwhat JD et al. Cryoablation of Barrett's esophagus: a pilot study. Gastrointest Endosc 2005; 62: 842-848
36. Dumot JA, Vargo JJ, Zuccaro G et al. Results of cryospray ablation for esophageal high grade dysplasia (HGD) and intramucosal cancer (IMCA) in high risk non-surgical patients. Gastrointest Endosc 2008; 67: AB176
37. Seewald S, Akaraviputh T, Seitz U et al. Circumferential EMR and complete removal of Barrett's epithelium: a new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. Gastrointest Endosc 2003; 57: 854-859
38. Giovannini M, Bories E, Pesenti C et al. Circumferential endoscopic mucosal resection in Barrett's esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients. Endoscopy 2004; 36: 782-787
39. Peters FP, Kara MA, Rosmolen WD et al. Stepwise radical endoscopic resection is effective for complete removal of Barrett's esophagus with early neoplasia: a prospective study. Am J Gastroenterol 2006; 101: 1449-1457
40. Larghi A, Lightdale CJ, Ross AS et al. Long term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma. Endoscopy 2007; 39: 1086-1091
41. Yoshinaga S, Gotoda T, Kusano C et al. Clinical impact of endoscopic submucosal dissection for superficial adenocarcinoma located at the esophagogastric junction. Gastrointest Endosc 2008; 67: 202-209
42. Spechler SJ, Sharma P, Traxler B et al. Gastric and esophageal pH in patients with Barrett's esophagus treated with three esomeprazole dosages: a randomized, double-blind, crossover trial. Am J Gastroenterol 2006; 101: 1964-1971
43. Sampliner RE, Camargo L, Fass R. Impact of esophageal acid exposure on the endoscopic reversal of Barrett's esophagus. Am J Gastroenterol 2002; 97: 270-272
44. Kovacs BJ, Chen YK, Lewis TD et al. Successful reversal of Barrett's esophagus with multipolar electrocoagulation despite inadequate acid suppression. Gastrointest Endosc 1999; 49: 547-553
45. Hornick JL, Mino-Kenudson M, Lauwers GY et al. Buried Barrett's epithelium following photodynamic therapy shows reduced crypt proliferation and absence of DNA content abnormalities. Am J Gastroenterol 2008; 103: 38-47
46. Ackroyd R, Brown NJ, Stephenson TJ et al. Ablation treatment for Barrett oesophagus: what depth of tissue destruction is needed? J Clin Pathol 1999; 52: 509-512
47. Leedham SJ, Preston SL, McDonald SA et al. Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett's oesophagus. Gut 2008; 57: 1041-1048
48. Weston AP, Sharma P, Banerjee S et al. Visible endoscopic and histologic changes in the cardia, before and after complete Barrett's esophagus ablation. Gastrointest Endosc 2005; 61: 515-521
49. Sampliner RE, Camargo E, Prasad AR. Association of ablation of Barrett's esophagus with high grade dysplasia and adenocarcinoma of the gastric cardia. Dis Esophagus 2006; 19: 277-279
50. Fass R, Garewal HS, Hayden CW et al. Preferential repair by squamous epithelium of thermal induced injury to the proximal stomach in patients undergoing ablation of Barrett's esophagus. Gastrointest Endosc 2001; 53: 711-716
51. Fennerty MB, Corless CL, Sheppard B et al. Pathological documentation of complete elimination of Barrett's metaplasia following endoscopic multipolar electrocoagulation therapy. Gut 2001; 49: 142-144
52. Prasad GA, Wang KK, Hailing KC et al. Utility of biomarkers in prediction of response to ablative therapy in Barrett's esophagus. Gastroenterology 2008; 135: 370-379